New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Considering taking a weight-loss drug like Ozempic? Here are some potential risks and benefits

Considering taking a weight-loss drug like Ozempic? Here are some potential risks and benefits

Considering taking a weight-loss drug like Ozempic? Here are some potential risks and benefitsby Lauren Ball and Emily Burch,The ConversationCredit: Unsplash/CC0 Public DomainAfter weight-loss d
Breakthroughs April 06,2024
Considering taking a weight-loss drug like Ozempic? Here are some potential risks and benefits

Considering taking a weight-loss drug like Ozempic? Here are some potential risks and benefits

Considering taking a weight-loss drug like Ozempic? Here are some potential risks and benefitsby Lauren Ball and Emily Burch,The ConversationCredit: Unsplash/CC0 Public DomainAfter weight-loss d
Breakthroughs April 06,2024
Research explores liberalization of medical marijuana and mental health in the US

Research explores liberalization of medical marijuana and mental health in the US

by University of BaselRegulation of (medical) marijuana across US states at the end of 2018. Credit:Health Economics, Policy and Law(2024). DOI: 10.1017/S1744133124000033The approval
Breakthroughs April 06,2024
Research explores liberalization of medical marijuana and mental health in the US

Research explores liberalization of medical marijuana and mental health in the US

by University of BaselRegulation of (medical) marijuana across US states at the end of 2018. Credit:Health Economics, Policy and Law(2024). DOI: 10.1017/S1744133124000033The approval
Breakthroughs April 06,2024
US company withdraws ALS drug after it fails in trial

US company withdraws ALS drug after it fails in trial

An MRI with increased signal in the posterior part of the internal capsule which can be tracked to the motor cortex consistent with the diagnosis of ALS. Credit: Frank Gaillard/WikipediaAmylyx Pharmac
Breakthroughs April 06,2024
US company withdraws ALS drug after it fails in trial

US company withdraws ALS drug after it fails in trial

An MRI with increased signal in the posterior part of the internal capsule which can be tracked to the motor cortex consistent with the diagnosis of ALS. Credit: Frank Gaillard/WikipediaAmylyx Pharmac
Breakthroughs April 06,2024
Biosimilar biologics do not always reduce out-of-pocket costs

Biosimilar biologics do not always reduce out-of-pocket costs

by Lori SolomonBiosimilar competition is not consistently associated with lower out-of-pocket (OOP) costs for commercially insured outpatients, according to a study published online March 29 inJ
Breakthroughs April 06,2024
Biosimilar biologics do not always reduce out-of-pocket costs

Biosimilar biologics do not always reduce out-of-pocket costs

by Lori SolomonBiosimilar competition is not consistently associated with lower out-of-pocket (OOP) costs for commercially insured outpatients, according to a study published online March 29 inJ
Breakthroughs April 06,2024
Testing found recalled medicine can have a deadly bacterial contamination

Testing found recalled medicine can have a deadly bacterial contamination

by David J. Neal, Miami HeraldCredit: Pixabay/CC0 Public DomainA drug used to treat a form of pneumonia has been recalled after testing found it might be as deadly as the infection it's supposed t
Breakthroughs April 06,2024
Testing found recalled medicine can have a deadly bacterial contamination

Testing found recalled medicine can have a deadly bacterial contamination

by David J. Neal, Miami HeraldCredit: Pixabay/CC0 Public DomainA drug used to treat a form of pneumonia has been recalled after testing found it might be as deadly as the infection it's supposed t
Breakthroughs April 06,2024
Combining multiple meds into a single pill reduces cardiovascular deaths, study confirms

Combining multiple meds into a single pill reduces cardiovascular deaths, study confirms

by Marley Wiemers,Washington University in St. LouisCredit: Unsplash/CC0 Public DomainTaking a single pill that combines medications targeting cardiovascular disease-related conditions was shown
Breakthroughs April 06,2024
Combining multiple meds into a single pill reduces cardiovascular deaths, study confirms

Combining multiple meds into a single pill reduces cardiovascular deaths, study confirms

by Marley Wiemers,Washington University in St. LouisCredit: Unsplash/CC0 Public DomainTaking a single pill that combines medications targeting cardiovascular disease-related conditions was shown
Breakthroughs April 06,2024
Existing drugs may hinder the development of bone metastasis in breast cancer patients

Existing drugs may hinder the development of bone metastasis in breast cancer patients

by Tel-Aviv UniversityCredit: CC0 Public DomainResearchers at Tel Aviv University developed a new therapeutic strategy based on existing medications to inhibit bone metastasis in breast cancer pa
Breakthroughs April 06,2024
Existing drugs may hinder the development of bone metastasis in breast cancer patients

Existing drugs may hinder the development of bone metastasis in breast cancer patients

by Tel-Aviv UniversityCredit: CC0 Public DomainResearchers at Tel Aviv University developed a new therapeutic strategy based on existing medications to inhibit bone metastasis in breast cancer pa
Breakthroughs April 06,2024
Research sheds light on effectiveness of FDA's black box warning for asthma drug

Research sheds light on effectiveness of FDA's black box warning for asthma drug

by University of OklahomaCredit: Pixabay/CC0 Public DomainA University of Oklahoma study about a "black box warning" for the asthma drug Singulair continues to influence a national conv
Breakthroughs April 06,2024
Research sheds light on effectiveness of FDA's black box warning for asthma drug

Research sheds light on effectiveness of FDA's black box warning for asthma drug

by University of OklahomaCredit: Pixabay/CC0 Public DomainA University of Oklahoma study about a "black box warning" for the asthma drug Singulair continues to influence a national conv
Breakthroughs April 06,2024
New research explains how brain blood vessels are formed

New research explains how brain blood vessels are formed

by Université libre de BruxellesMmp25 as a regulator of brain-specific angiogenesis.a, The TC genotype in mosaic sprouts during brain vascular invasion (36 hpf,n = 23 sprouts) and tru
Neurology April 06,2024
New research explains how brain blood vessels are formed

New research explains how brain blood vessels are formed

by Université libre de BruxellesMmp25 as a regulator of brain-specific angiogenesis.a, The TC genotype in mosaic sprouts during brain vascular invasion (36 hpf,n = 23 sprouts) and tru
Neurology April 06,2024
Chemical regulates light processing differently in the autistic and non-autistic eye, new study finds

Chemical regulates light processing differently in the autistic and non-autistic eye, new study finds

by King's College LondonCredit: Pixabay/CC0 Public DomainKing's College London researchers have shown that the brain chemical GABA regulates activity in the retina of the eye in autistic
Neurology April 06,2024
Chemical regulates light processing differently in the autistic and non-autistic eye, new study finds

Chemical regulates light processing differently in the autistic and non-autistic eye, new study finds

by King's College LondonCredit: Pixabay/CC0 Public DomainKing's College London researchers have shown that the brain chemical GABA regulates activity in the retina of the eye in autistic
Neurology April 06,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com